The honest answer
Search for how to store a reconstituted peptide and you will find the same line repeated: keep it in the fridge and it lasts about a month. It is tidy, memorable, and not a fact about peptides.
Storage is decided product by product. A manufacturer tests its own formulation at set temperatures, measures how fast it breaks down, and prints the result on the label. For approved products those results differ enormously, as the table below shows. For most peptides sold for research use, the test has never been published, so there is nothing to print.
This article explains why a solution is less stable than a powder, shows what approved labels actually say, and is clear about where knowledge runs out. It does not give a storage time for any compound.
Why a solution is less stable than a powder
Peptides are supplied freeze-dried for a reason. A 2023 review of therapeutic peptide stability puts it plainly: peptides “are often unstable in aqueous solutions, affecting stability and bioactivity”. Removing the water slows that down, which is why freeze-drying is the standard way to give such products a usable shelf life.
Adding liquid starts the clock again. The same review describes two kinds of breakdown:
- Chemical changes, including oxidation, hydrolysis and deamidation, which alter the molecule itself.
- Physical changes, including aggregation (molecules clumping together), adsorption to surfaces, and precipitation.
How fast any of this happens depends on the specific peptide, the pH, and whatever else is in the formulation. That is why one product’s shelf life says nothing about another’s.
What speeds the breakdown up
The literature points to the same handful of stresses.
- Temperature. The review notes that most peptide drugs need storage and transport at low temperatures, and that heating can induce aggregation. Most is not all, as the next section shows.
- Light. Light exposure is one of the things that can trigger oxidation. Several labels say to keep vials in the original box for this reason.
- Agitation. Shaking and shear stress can cause aggregation, which is why mixing instructions say not to shake.
- Freezing. Also listed among the stresses that can induce aggregation. Every approved label below that mentions freezing says not to.
- Contamination. Every time a needle enters a vial there is a chance of introducing bacteria. This is a separate problem from chemical stability, with a separate clock.
What FDA-approved labels actually say
Here are five approved products that are reconstituted before use. The storage statements are taken from their current labels.
| Product | After mixing | Before mixing |
|---|---|---|
| Egrifta SV (tesamorelin) | Use right away. “Do not store, freeze or refrigerate” | Room temperature, 20–25°C, protected from light |
| Egrifta WR (tesamorelin) | Room temperature, 20–25°C. Discard 7 days after mixing. Do not freeze or refrigerate | Room temperature, 20–25°C, in the original box |
| Glucagon emergency kit | “Use reconstituted Glucagon for Injection immediately. Discard unused portion” | 20–25°C, do not freeze, away from light |
| Novarel (chorionic gonadotropin) | Refrigerate at 2–8°C and use within 30 days | Room temperature, 20–25°C |
| Pregnyl (chorionic gonadotropin) | Refrigerate at 2–8°C, discard after 60 days. Do not freeze | Controlled room temperature, 15–25°C |
Three things stand out.
The range is enormous. From “immediately” to 60 days.
The fridge is not universal. Two of the five labels say the mixed solution must not be refrigerated. One is kept at room temperature for a week.
Even the same hormone differs. Novarel and Pregnyl are both chorionic gonadotropin, mixed with a preserved diluent and refrigerated, and one label says 30 days while the other says 60. The formulation decides, not the name of the molecule.
If five tested products disagree this much, a single rule of thumb for untested ones cannot be right.
Ready-made solutions are different again
Many GLP-1 medicines are not reconstituted at all. They are supplied as finished solutions, with their own rules.
- Zepbound single-dose vial and pen: stored in a refrigerator at 2°C to 8°C, and if needed “can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days”.
- Ozempic pen: refrigerated before first use. After first use it “can be stored for 56 days” at controlled room temperature or in a refrigerator.
Other presentations of the same medicines carry different figures, so the label for the exact product in hand is the one that counts. A compounded version of either drug is a different product again, and its pharmacy’s instructions apply.
The diluent has its own clock
The liquid used for mixing is a separate product with separate rules.
Bacteriostatic water comes in a multiple-dose container and contains a preservative. For opened multiple-dose vials in general, the CDC, citing the USP chapter on sterile compounding, says the vial “should be dated and discarded within 28 days unless the manufacturer states another date”. The Egrifta WR labelling gives the same figure for its own diluent, telling patients to discard any bacteriostatic water left in the bottle 28 days after first use.
The CDC is also clear about what a preservative can and cannot do: it “does not have an effect on viruses nor does it provide complete protection against bacterial contamination”.
Sterile water for injection has no preservative and is labelled single-dose. Its label says to discard the unused portion.
Neither clock says anything about how long a peptide dissolved in that liquid stays stable. The preservative holds back bacteria. It does nothing for the chemistry.
Research peptides: what is actually known
For an approved product, somebody ran a stability study and a regulator reviewed it. For most peptides sold “for research use only”, no study of the reconstituted product has been published. That leaves real unknowns:
- Storage times quoted by sellers and forums are usually not backed by published data.
- A vial’s contents, purity and formulation may not match an approved product of the same name, so its label figures do not transfer.
- A solution can degrade, or become contaminated, without looking any different.
This is one reason such products carry more risk than the math around them suggests. A peptide calculator can be exact about a concentration on the day of mixing. It knows nothing about what is in the vial three weeks later.
What to write down
Whatever the product’s rules are, they can only be followed if two dates are known: when the vial was mixed, and when its labelling says to discard it. Neither is printed anywhere once liquid has gone in.
For each vial, record the date it was reconstituted, the diluent and volume, the storage instruction from its labelling, and the discard date that follows from it. Peptrack keeps each vial’s details with its log, including an expiry date you set, so the date is in front of you when you log against it. The app does not choose that date. It comes from the product’s labelling or your pharmacist.
For the mixing stage itself, see how to reconstitute peptides. To work out a vial’s concentration, use the reconstitution calculator, and for the background on diluents and vial labels, the peptide reconstitution guide.
Sources
Factual statements in this article come from these primary sources, last checked in September 2026.
- DailyMed: Egrifta SV (tesamorelin) label
- DailyMed: Egrifta WR (tesamorelin) label
- DailyMed: Glucagon for Injection emergency kit (Amphastar) label
- DailyMed: Novarel (chorionic gonadotropin, Ferring) label
- DailyMed: Pregnyl (chorionic gonadotropin, Organon) label
- DailyMed: Zepbound (tirzepatide, Eli Lilly) label
- DailyMed: Ozempic (semaglutide, Novo Nordisk) label
- CDC: Preventing Unsafe Injection Practices (multi-dose vials, citing USP 797)
- Nugrahadi PP et al. Designing formulation strategies for enhanced stability of therapeutic peptides in aqueous solutions: a review. Pharmaceutics 2023;15(3):935
- Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics 2000;203:1-60
